Leap Health

Specialty infusion drugs are among the fastest-growing costs in employer healthcare, and the legacy model runs on hidden markups that can exceed 400%. Leap rebuilds that journey from the ground up: it integrates directly with health plans, prices therapies transparently, and brings treatment to a patient's home or a nearby location with evening and weekend appointments. The payoff is lower cost for employers and fewer lost workdays for patients on long-term therapies for conditions like multiple sclerosis, Crohn's disease, and other autoimmune conditions.

The team skews heavily toward patient-facing work: Care Guides, intake, and clinical operations coordinate treatment in real time, alongside a small but fast-growing engineering group building AI and automation into the care platform. It is an early-stage company scaling quickly, with several founding roles open across clinical, engineering, sales, and operations.